Cost Guide
GLP-1 Medication Costs: Insurance Guide
GLP-1 medication costs vary from $149/month for orforglipron to over $1,350/month for Wegovy. Complete guide to insurance coverage, savings programs, LillyDirect, and every way to reduce costs.
01
The Real Cost Picture in 2026
| Medication | Monthly list price | With insurance (typical copay) | Self-pay options |
|---|---|---|---|
| Wegovy (sema 2.4 mg) | ~$1,350 | $25-150 | Novo Nordisk savings card: as low as $0 for eligible patients |
| Ozempic (sema 1.0 mg, T2D) | ~$935 | $25-100 | Savings card available |
| Zepbound (tirz 15 mg) | ~$1,060 | $25-150 | LillyDirect self-pay: ~$549/month |
| Mounjaro (tirz, T2D) | ~$1,060 | $25-100 | Savings card available |
| Orforglipron (expected 2026) | — | TBD | LillyDirect: $149-399/month |
| CagriSema (expected 2027) | TBD | TBD | Expected premium to Wegovy |
02
Semaglutide Coverage Summary
| Indication | Brand | Coverage status |
|---|---|---|
| Type 2 diabetes | Ozempic | Widely covered |
| Weight management | Wegovy | Increasingly covered, but inconsistent |
| Cardiovascular risk reduction | Wegovy | Improving (SELECT trial data) |
03
Tirzepatide Coverage Summary
| Indication | Brand | Coverage status |
|---|---|---|
| Type 2 diabetes | Mounjaro | Widely covered |
| Weight management | Zepbound | Mixed (expanding) |
| Self-pay | Zepbound via LillyDirect | Available now (~$549/month) |
04
Upcoming Medications
| Medication | Expected availability | Expected self-pay |
|---|---|---|
| Orforglipron | 2026 | $149-399/month |
| CagriSema | 2027 | TBD (expected premium) |
| Retatrutide | ~2027 | TBD |
FAQ
Frequently asked questions
References
- 01Novo Nordisk. NovoCare Patient Assistance Programs. 2026.
- 02Eli Lilly. LillyDirect Pricing and Availability. 2025-2026.
- 03Centers for Medicare & Medicaid Services. Medicare Part D Coverage Updates. 2025.
- 04GoodRx Research. "GLP-1 Medication Pricing Trends." 2025.
- 05American Diabetes Association. "Standards of Medical Care in Diabetes." 2025.
- 06Eli Lilly. "Orforglipron Pricing Announcement." 2025.
This profile is being expanded — additional sections from the source are still being added.
Related in the library